EFFECTIVENESS Tirzepatide has been studied in a trial of 2,539 patients who had obesity but not diabetes, with a BMI of more than 30 kg per m 2 or a BMI of more than 27 kg per m 2 plus at least one weight-related comorbid condition
Overall, the clinical impression, serological findings and histological features were consistent with drug-induced liver injury likely secondary to Mounjaro
Individual pain thresholds and anxiety about self-injection may influence subjective reporting of injection site discomfort
Though it is not an overnight transformation, youll see steady and sustainable results
By sticking to the plan and checking heart health, people can lower their chance of heart attack and feel better overall
Injections are subcutaneous into the abdomen, thigh, or upper arm